Gene · 186
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1. | Aging Cell | 2022 | 35645319 | PubTator, text mining | PubMed |
| Pregnancy, Preeclampsia, and COVID-19: Susceptibility and Mechanisms: A Review Study. | Int J Fertil Steril | 2022 | 35639648 | PubTator, text mining | PubMed |
| Comprehensive network analysis of dysregulated genes revealed MNX1-AS1/hsa-miR-4697-3p/HOXB13 axis in ovarian cancer chemotherapy response. | Cancer Sci | 2022 | 35639251 | PubTator, text mining | PubMed |
| Pre-miRNA Hsa-Let-7a-2: a Novel Intracellular Partner of Angiotensin II Type 2 Receptor Negatively Regulating its Signals. | Int J Biol Sci | 2022 | 35637969 | PubTator, text mining | PubMed |
| Integrative Analysis of Small RNA and mRNA Expression Profiles Identifies Signatures Associated With Chronic Epididymitis. | Front Immunol | 2022 | 35634321 | PubTator, text mining | PubMed |
| Exercise Normalized the Hippocampal Renin-Angiotensin System and Restored Spatial Memory Function, Neurogenesis, and Blood-Brain Barrier Permeability in the 2K1C-Hypertensive Mouse. | Int J Mol Sci | 2022 | 35628344 | PubTator, text mining | PubMed |
| Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. | Cancers (Basel) | 2022 | 35625966 | PubTator, text mining | PubMed |
| Plasma angiotensin peptides as biomarkers of rheumatoid arthritis are correlated with anti-ACE2 auto-antibodies level and disease intensity. | Inflammopharmacology | 2022 | 35618976 | PubTator, text mining | PubMed |
| Development and verification of the nomogram for dilated cardiomyopathy gene diagnosis. | Sci Rep | 2022 | 35618744 | PubTator, text mining | PubMed |
| Delineating the conformational landscape and intrinsic properties of the angiotensin II type 2 receptor using a computational study. | Comput Struct Biotechnol J | 2022 | 35615027 | PubTator, text mining | PubMed |
| Endotheliitis, Shunts, and Ventilation-Perfusion Mismatch in Coronavirus Disease 2019: A Literature Review of Disease Mechanisms. | Ann Med Surg (Lond) | 2022 | 35600188 | PubTator, text mining | PubMed |
| Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats. | Neurotoxicology | 2022 | 35594946 | PubTator, text mining | PubMed |
| Association of ACE2 Polymorphisms and Derived Haplotypes With Obesity and Hyperlipidemia in Female Spanish Adolescents. | Front Cardiovasc Med | 2022 | 35586646 | PubTator, text mining | PubMed |
| Angiotensin II receptor blockers (ARBs) and manufacturing contamination: A retrospective National Register Study into suspected associated adverse drug reactions. | Br J Clin Pharmacol | 2022 | 35585835 | PubTator, text mining | PubMed |
| The term CAKUT has outlived its usefulness: the case for the prosecution. | Pediatr Nephrol | 2022 | 35575937 | PubTator, text mining | PubMed |
| The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet. | Kidney Int Rep | 2022 | 35570989 | PubTator, text mining | PubMed |
| The Pathophysiology of Long COVID throughout the Renin-Angiotensin System. | Molecules | 2022 | 35566253 | PubTator, text mining | PubMed |
| Variations in the Gene Expression Profile in Atherosclerotic Patients with Non-Fatal ACS: A Preliminary Study. | Int J Mol Sci | 2022 | 35563407 | PubTator, text mining | PubMed |
| Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19. | J Cell Commun Signal | 2022 | 35525888 | PubTator, text mining | PubMed |
| Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease. | Front Pharmacol | 2022 | 35517809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/186/papers?page=18